CAT No: CP00812
CAS No:71989-20-3
Synonyms/Alias:Fmoc-Gln-OH;71989-20-3;Fmoc-L-glutamine;N-Fmoc-L-Glutamine;Nalpha-Fmoc-L-glutamine;Fmoc-L-Gln-OH;(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-amino-5-oxopentanoicacid;ST50307202;118609-68-0;Nalpha-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-glutamine;N-[(9H-FLUOREN-9-YLMETHOXY)CARBONYL]-L-GLUTAMINE;(2S)-4-carbamoyl-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}butanoicacid;N(alpha)-Fluorenylmethoxycarbonylglutamine;(2S)-4-CARBAMOYL-2-([(9H-FLUOREN-9-YLMETHOXY)CARBONYL]AMINO)BUTANOICACID;Fmoc-alpha-Glutamine;FMOC-GLN;FMOC-L-GLN;AC1MC5MZ;AC1Q4ZK3;N-ALPHA-FMOC-L-GLN;N-.alpha.-Fmoc-L-glutamine;N-A-FMOC-L-GLUTAMINE;47626_ALDRICH;SCHEMBL119475;47626_FLUKA
2. Implications of ligand-receptor binding kinetics on GLP-1R signalling
3. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum
5. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More